Common variable immunodeficiency and granulomatosis treated with infliximab

Clinical Immunology

Volumn 134, Issue 3, 2010, Pages 359-360

  Malbrán, Alejandro ^a   Juri, María C ^a   Fernández Romero, Diego S ^a  

^a Servicio de Alergia e Inmunología ^*  (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; INFLIXIMAB; METHYLPREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; CASE REPORT; COMMON VARIABLE IMMUNODEFICIENCY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; GRANULOMATOSIS; HUMAN; LETTER; LEUKOCYTOCLASTIC VASCULITIS; PRIORITY JOURNAL; RELAPSE; SKIN BIOPSY; SKIN MANIFESTATION; TREATMENT RESPONSE;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; GRANULOMA; HUMANS; MIDDLE AGED;

EID: 76049117431     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2009.11.014     Document Type: Letter

References (5)

1. Ardeniz Ö., and Cunningham-Rundles C. Granulomatous disease in common variable immunodeficiency. Clin. Immunol. 133 (2009) 198-207
2. Thatayatikom A., Thatayatikom S., and White A.J. Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature. Ann. Allergy Asthma Immunol. 95 3 (2005 Sep) 293-300
3. Hatab A.Z., and Ballas Z.K. Caseating granulomatous disease in common variable immunodeficiency treated with infliximab. J. Allergy Clin. Immunol. 116 5 (2005 Nov) 1161-1162
4. Lin J.H., Liebhaber M., Roberts R.L., Dyer Z., and Stiehm E.R. Etanercept treatment of cutaneous granulomas in common variable immunodeficiency. J. Allergy Clin. Immunol. 117 4 (2006 Apr) 878-882
5. Smith K.J., and Skelton H. Common variable immunodeficiency treated with a recombinant human IgG, tumour necrosis factor-α receptor fusion protein. Br. J. Dermatol. 144 (2001) 597-600